Cite
HARVARD Citation
Selle, F. et al. (n.d.). 2766 Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial. European journal of cancer. pp. S553-. [Online].